摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(R)-6,8-dimercaptooctanoic acid methyl ester | 1170960-47-0

中文名称
——
中文别名
——
英文名称
(R)-6,8-dimercaptooctanoic acid methyl ester
英文别名
(R)-6,8-Dimercapto-octansaeure-methylester;methyl (6R)-6,8-bis(sulfanyl)octanoate
(R)-6,8-dimercaptooctanoic acid methyl ester化学式
CAS
1170960-47-0
化学式
C9H18O2S2
mdl
——
分子量
222.373
InChiKey
SPKLEZPOTBFJPB-MRVPVSSYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    305.4±32.0 °C(Predicted)
  • 密度:
    1.063±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    13
  • 可旋转键数:
    8
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.89
  • 拓扑面积:
    28.3
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Synthesis and evaluation of some novel isochroman carboxylic acid derivatives as potential anti-diabetic agents
    摘要:
    A series of novel isochroman mono-carboxylic acid derivatives were synthesized, characterized and evaluated for their ability to inhibit protein tyrosine phosphatase 1B (PTP1B) in vitro in order to use them as potential anti-diabetic agents. Analysis of structure-activity relationships led to the identification of potent compound 4n which inhibited PTP1B with IC50 value of 51.63 +/- 0.91 nM. In general, high potency was associated with a dithiolane ring with a spacer of five carbons to the isochroman ring. Compound 4n has been selected for in vivo evaluation as drug candidate for anti-diabetic activity. (C) 2009 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2009.03.009
  • 作为产物:
    描述:
    R-(+)-硫辛酸甲醇 、 sodium tetrahydroborate 、 氯化亚砜 作用下, 反应 6.0h, 生成 (R)-6,8-dimercaptooctanoic acid methyl ester
    参考文献:
    名称:
    2-Azaadamantane N-氧基(AZADO)/ Cu催化可实现含电子丰富的二价硫官能团的醇的化学选择性好氧氧化
    摘要:
    在现代有机化学中,有时将含有富电子功能的硫官能团(例如1,3-二硫醚和硫化物)的醇化学选择性氧化成其相应的具有硫基的羰基化合物,这可能是一项艰巨的任务。报道了这种转化的可靠方法,其特征在于使用环境空气作为末端氧化剂的氮杂金刚烷型硝基氧基自由基/铜催化。通过与各种常规醇氧化方法进行比较,证明了所开发方法的优越性。
    DOI:
    10.1021/acs.orglett.8b02528
点击查看最新优质反应信息

文献信息

  • Biosynthesis and Structure of Lipoic Acid Derivatives<sup>1</sup>
    作者:I. C. Gunsalus、Lois S. Barton、W. Gruber
    DOI:10.1021/ja01589a079
    日期:1956.4
  • 2-Azaadamantane<i>N</i>-oxyl (AZADO)/Cu Catalysis Enables Chemoselective Aerobic Oxidation of Alcohols Containing Electron-Rich Divalent Sulfur Functionalities
    作者:Yusuke Sasano、Naoki Kogure、Shota Nagasawa、Koki Kasabata、Yoshiharu Iwabuchi
    DOI:10.1021/acs.orglett.8b02528
    日期:2018.10.5
    The chemoselective oxidation of alcohols containing electron-rich sulfur functionalities (e.g., 1,3-dithianes and sulfides) into their corresponding carbonyl compounds with the sulfur groups can sometimes be a demanding task in modern organic chemistry. A reliable method for this transformation, which features azaadamantane-type nitroxyl radical/copper catalysis using ambient air as the terminal oxidant
    在现代有机化学中,有时将含有富电子功能的硫官能团(例如1,3-二硫醚和硫化物)的醇化学选择性氧化成其相应的具有硫基的羰基化合物,这可能是一项艰巨的任务。报道了这种转化的可靠方法,其特征在于使用环境空气作为末端氧化剂的氮杂金刚烷型硝基氧基自由基/铜催化。通过与各种常规醇氧化方法进行比较,证明了所开发方法的优越性。
  • Synthesis and evaluation of some novel isochroman carboxylic acid derivatives as potential anti-diabetic agents
    作者:N. Lakshminarayana、Y. Rajendra Prasad、Laxmikant Gharat、Abraham Thomas、P. Ravikumar、Shridhar Narayanan、C.V. Srinivasan、Balasubramanian Gopalan
    DOI:10.1016/j.ejmech.2009.03.009
    日期:2009.8
    A series of novel isochroman mono-carboxylic acid derivatives were synthesized, characterized and evaluated for their ability to inhibit protein tyrosine phosphatase 1B (PTP1B) in vitro in order to use them as potential anti-diabetic agents. Analysis of structure-activity relationships led to the identification of potent compound 4n which inhibited PTP1B with IC50 value of 51.63 +/- 0.91 nM. In general, high potency was associated with a dithiolane ring with a spacer of five carbons to the isochroman ring. Compound 4n has been selected for in vivo evaluation as drug candidate for anti-diabetic activity. (C) 2009 Elsevier Masson SAS. All rights reserved.
查看更多